Intellectual Property

"An impressive firm that is very much on the ball. They explain very clearly the pros and cons of a certain strategy and help us to the best outcome.’” – Chambers USA

Cadwalader's Intellectual Property team is known for its depth of experience and exceptional capabilities in all intellectual property matters. Our lawyers help clients maximize their investments in intellectual property and protect their market assets, whether that requires enforcing or defending IP claims in litigation and trials, or providing expert opinions, or evaluating and selling or licensing intellectual property, or obtaining comprehensive/strategic IP protection, or conducting due diligence.

The lawyers who advise in these areas include a growing number of nationally and internationally recognized intellectual property lawyers who hold Ph.D., bio-medical, engineering and other advanced scientific degrees and who are highly experienced in range of technologies - mechanical and electro-mechanical subject matters, computer hardware/software, business methods, financial services, cellular telephone and semiconductor technologies, sophisticated medical devices, chemical and pharmaceutical matters, and complex biotechnologies. Our lawyers have even helped clients obtain pioneer patent protection in new emerging technologies, such as the famous "Priceline" patent, which was successfully asserted in litigation.

Many of our IP lawyers have also been serving in prestigious leadership positions with and remain active members of key bar associations, including the New York Intellectual Property Law Association (NYIPLA), the International Trade Commission Trial Lawyers Association (ITCTLA), the American Intellectual Property Law Association (AIPLA), the Licensing Executives Society (LES), Intellectual Property Owners (IPO), the Patent, Trademark & Copyright Law and Intellectual Property Sections of the New York State Bar Association and the American Bar Association.

  • 3D4Medical Ltd. in actions against Orca Health, Inc. In one action, we defended 3D4Medical in Utah Federal District Court where Orca Health alleged over 10 state and federal tort claims, including unfair competition, trade secret misappropriation, and infringement of its trademarks, trade dress and patents.  Before discovery began, we filed multiple motions to dismiss the complaint under rule 12(b)(6) as well as a motion to disqualify plaintiff’s counsel and to invalidate the asserted patents as being directed to ineligible subject matter.  In addition, we filed a separate lawsuit in the Southern California Federal District Court against Orca Health for copyright infringement, trade dress infringement, unfair competition and breach of obligations under its End User License Agreement with 3D4Medical.  After having already dismissed one of the two patents from case and just before the hearing on the Utah preliminary motions, a favorable settlement of both cases was reached.

  • Zhengzhou Jinhui Computer System Engineering, Ltd. as co-defendant in a copyright infringement and trade secret action
  • IBM in a multi-defendant patent infringement suit in E.D. Texas 
  • Angiodynamics as defendant in a patent infringement suit on patent relating to catheter devices 
  • Merck & Co. in Hatch Waxman patent cases against Hetero Drugs Ltd. and Hetero USA Inc. involving Merck's Propecia product, a treatment for male pattern hair loss alleging infringement of patents for methods of treating androgenic alopecia following a Paragraph IV certification as part of Hetero's filing of an Abbreviated New Drug Application to manufacture a generic version of Propecia
  • Real Estate Alliance Ltd. (REAL) in a patent case involving more than 35 real estate industry participants, including popular website operators, trade associations, and software providers, who allegedly infringe REAL's pioneer patent describing mapping methods for locating available real estate properties for sale, lease, or rental using a database of available properties
  • General Atomics as a cross-claimant alleging, inter alia, trade secret misappropriation by a former employee and his new company dealing with laser-based three dimensional imaging systems
  • Medinol in defending Abbott's appeal of a determination of patent infringement
  • Medinol in German Nullity Proceeding brought by Abbott with respect to Medinol patents in the German Federal Patent Court

NEWS

News Releases

view more »

Recognition

view more »

RESOURCES

15 Attorneys

Absolonne, Deirdre Long Special Counsel New York
T. +1 212 504 6608
Auth Ph.D., Dorothy R. Partner New York
T. +1 212 504 6018
Cole, Dash Associate New York
T. +1 212 504 6755
DeVries, Katherine Law Clerk
T. +1 212 504 6181
Hughes, Christopher A. Senior Counsel New York
T. +1 212 504 6891
Martin, Monica Law Clerk New York
T. +1 212 504 6145
Moehringer, John T. Partner New York
T. +1 212 504 6731
Moll, Peter E. Partner Washington
T. +1 202 862 2220
Orth, James Law Clerk New York
T. +1 212 504 6185
Pollaro, Robert M. Special Counsel New York
T. +1 212 504 6484
Powell, Michael B. Associate New York
T. +1 212 504 6246
Sebba, Michael J. Associate New York
T. +1 212 504 6523
Tully, Danielle Vincenti Associate New York
T. +1 212 504 6585
Wallach, Brian Partner Washington
T. +1 202 862 2332
Wizenfeld, Howard Special Counsel New York
T. +1 212 504 6050

Contact(s)

Christopher A. Hughes
+1 212 504 6891 
christopher.hughes@cwt.com
v-card

Cadwalader News

ACI Summit on Controlled Substances: Regulation, Litigation and Enforcement

Jodi Avergun is speaking at this ACI event on January 30 in Washington, DC.

Cadwalader Subscription Center